NPPA and myeloid sarcoma: Accordingly, we examined the role of the KP in MS progression as it potentially links inflammation-induced activation of the KP10, the production of the glutamatergic (NMDA)-modulatory metabolites, KA and QA, to excitotoxic neurodegeneration11, 12, 13.